openPR Logo
Press release

Cataract Market and Epidemiology 2032: Treatment Therapies, Epidemiology and Companies by DelveInsight | Aerie Pharmaceuticals, Allergan, Bausch Health, Merck, Pfizer, Teva Pharma, Amorphex Therapeutics, Alcon, Astellas Pharma, Bayer, Novartis, AstraZenec

06-12-2023 06:06 AM CET | Health & Medicine

Press release from: DelveInsight Business Research

Cataract Market

Cataract Market

(New York, USA) DelveInsight's "Cataract Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Cataract, historical and forecasted epidemiology as well as the Cataract market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.

Request for a Free Sample Report @ https://www.delveinsight.com/report-store/cataract-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Some facts of the Cataract Market Report are:
• According to DelveInsight, Cataract market size is expected to grow at a decent CAGR by 2032.
• Leading Cataract companies working in the market are Aerie Pharmaceuticals, Allergan, Bausch Health, Merck, Pfizer Inc, Teva Pharmaceutical, Amorphex Therapeutics, Alcon, Astellas Pharma Inc., Bayer AG, Novartis AG, AstraZeneca, Amgen, Carl Zeiss Meditec, HumanOptics Holding AG, STAAR SURGICAL, SIFI SpA, Sintesi Research Srl, EyePoint Pharmaceuticals, Alcon Research, Nacuity Pharmaceuticals, TearLab Corporation and others.
• Promising Cataract Therapies expected to launch in the market are NETILDEX™ eye drops solution, Dexamethasone, Prednisolone Acetate Ophthalmic, MELT-300, Midazolam, Ketamine, Healon, Amvisc Plus, NPI-002 Intravitreal Implant, Dexycu, Vigadexa, and others.
• Rising Incidence of Cataract and increasing Demand for Retail Pharmacies are some of the factors affecting cataract market growth.

Cataract Overview

Cataract is a common eye condition that affects the lens of the eye, causing it to become cloudy. The lens is responsible for focusing light onto the retina at the back of the eye, allowing us to see clear images. When a cataract develops, it interferes with the normal passage of light, leading to blurred or hazy vision.

Cataracts typically develop slowly over time and are more commonly seen in older individuals. However, they can also occur in younger people due to various factors such as genetics, trauma to the eye, certain medications, or medical conditions like diabetes. Long-term exposure to ultraviolet radiation from the sun, smoking, and alcohol consumption may also increase the risk of developing cataracts.

Learn more about Cataract treatment algorithms in different geographies, and patient journeys. Contact to receive a sample @ https://www.delveinsight.com/sample-request/cataract-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Cataract Market

The Cataract market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted Cataract market trends by analyzing the impact of current Cataract therapies on the market and unmet needs, and drivers, barriers, and demand for better technology.

This segment gives a thorough detail of the Cataract market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Cataract market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Cataract market in 7MM is expected to witness a major change in the study period 2019-2032.

Cataract Epidemiology

The Cataract epidemiology section provides insights into the historical and current Cataract patient pool and forecasted trends for seven individual major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Cataract market report also provides the diagnosed patient pool, trends, and assumptions.

Explore more about Cataract Epidemiology @ https://www.delveinsight.com/sample-request/cataract-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Cataract Drugs Uptake

This section focuses on the uptake rate of the potential Cataract drugs recently launched in the Cataract market or expected to be launched in 2019-2032. The analysis covers the Cataract market uptake by drugs, patient uptake by therapies, and sales of each drug.

Cataract Drugs Uptake helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs and allows the comparison of the drugs based on Cataract market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Cataract Pipeline Development Activities

The Cataract report provides insights into different therapeutic candidates in Phase II, and Phase III stages. It also analyses Cataract key players involved in developing targeted therapeutics.

Request for a sample report to understand more about the Cataract pipeline development activities @ https://www.delveinsight.com/sample-request/cataract-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Cataract Therapeutics Assessment

Major key companies are working proactively in the Cataract Therapeutics market to develop novel therapies which will drive the Cataract treatment markets in the upcoming years are Aerie Pharmaceuticals, Allergan, Bausch Health, Merck, Pfizer Inc, Teva Pharmaceutical, Amorphex Therapeutics, Alcon, Astellas Pharma Inc., Bayer AG, Novartis AG, AstraZeneca, Amgen, Carl Zeiss Meditec, HumanOptics Holding AG, STAAR SURGICAL, SIFI SpA, Sintesi Research Srl, EyePoint Pharmaceuticals, Alcon Research, Nacuity Pharmaceuticals, TearLab Corporation and others.

Learn more about the emerging Cataract therapies & key companies @ https://www.delveinsight.com/sample-request/cataract-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Cataract Report Key Insights

1. Cataract Patient Population
2. Cataract Market Size and Trends
3. Key Cross Competition in the Cataract Market
4. Cataract Market Dynamics (Key Drivers and Barriers)
5. Cataract Market Opportunities
6. Cataract Therapeutic Approaches
7. Cataract Pipeline Analysis
8. Cataract Current Treatment Practices/Algorithm
9. Impact of Emerging Therapies on the Cataract Market

Table of Contents

1. Key Insights
2. Executive Summary
3. Cataract Competitive Intelligence Analysis
4. Cataract Market Overview at a Glance
5. Cataract Disease Background and Overview
6. Cataract Patient Journey
7. Cataract Epidemiology and Patient Population
8. Cataract Treatment Algorithm, Current Treatment, and Medical Practices
9. Cataract Unmet Needs
10. Key Endpoints of Cataract Treatment
11. Cataract Marketed Products
12. Cataract Emerging Therapies
13. Cataract Seven Major Market Analysis
14. Attribute Analysis
15. Cataract Market Outlook (7 major markets)
16. Cataract Access and Reimbursement Overview
17. KOL Views on the Cataract Market
18. Cataract Market Drivers
19. Cataract Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer

Get the Detailed TOC of the Cataract Market report here @ https://www.delveinsight.com/sample-request/cataract-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Trending Reports:
• Bronchial Spasm Market: https://www.delveinsight.com/report-store/bronchial-spasm-market
• Meningioma Market: https://www.delveinsight.com/report-store/meningioma-market
• Necrotizing Enterocolitis Market: https://www.delveinsight.com/report-store/necrotizing-enterocolitis-market
• Hyperhidrosis Market: https://www.delveinsight.com/report-store/hyperhidrosis-market
• Bacterial Meningitis Market: https://www.delveinsight.com/report-store/bacterial-meningitis-market
• Anaphylaxis Market: https://www.delveinsight.com/report-store/anaphylaxis-market
• Neurostimulation Devices Market: https://www.delveinsight.com/report-store/neurostimulation-devices-market
• Intracranial Pressure Monitoring Devices Market: https://www.delveinsight.com/report-store/intracranial-pressure-monitoring-devices-market
• Acute Pharyngitis Market: https://www.delveinsight.com/report-store/acute-pharyngitis-epidemiology-forecast
• Hepatitis B Virus Market: https://www.delveinsight.com/infographics/chronic-hepatitis-b-virus-market
• Thymic Carcinoma Market: https://www.delveinsight.com/report-store/thymic-carcinoma-market
• Bladder Cancer Market: https://www.delveinsight.com/report-store/bladder-cancer-market
• Spasticity Market: https://www.delveinsight.com/report-store/spasticity-market
• Interbody Cages Market: https://www.delveinsight.com/report-store/interbody-cages-market
• Helicobacter Pylori Infection Market: https://www.delveinsight.com/report-store/helicobacter-pylori-h-pylori-infection-market
• Intravenous Immunoglobulin Market: https://www.delveinsight.com/report-store/intravenous-immunoglobulin-market
• Opioid Induced Constipation Market: https://www.delveinsight.com/report-store/opioid-induced-constipation-market
• Ophthalmic Imaging Equipment Market: https://www.delveinsight.com/report-store/ophthalmic-imaging-equipment-market
• Epilepsy Market: https://www.delveinsight.com/report-store/epilepsy-market
• Pharmaceutical Consulting Companies: https://www.delveinsight.com/consulting
• Acquired Immunodeficiency Syndrome Market: https://www.delveinsight.com/report-store/acquired-immunodeficiency-syndrome-aids-market
• Image Guided Surgery Devices Market: https://www.delveinsight.com/report-store/image-guided-surgery-devices-market
• Androgenetic Alopecia Market: https://www.delveinsight.com/blog/androgenetic-alopecia-treatment-outlook
• Acute Lung Injury Market: https://www.delveinsight.com/report-store/acute-lung-injury-market
• Astigmatism Market: https://www.delveinsight.com/report-store/bacterial-meningitis-market
• Familial Primary Pulmonary Hypertension Market: https://www.delveinsight.com/report-store/familial-primary-pulmonary-hypertension-market
• Progressive Multifocal Leukoencephalopathy Market: https://www.delveinsight.com/report-store/progressive-multifocal-leukoencephalopathy-market

Contact Us:

Ankit Nigam
info@delveinsight.com
+1(919)321-6187
https://www.delveinsight.com/consulting

About DelveInsight

DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cataract Market and Epidemiology 2032: Treatment Therapies, Epidemiology and Companies by DelveInsight | Aerie Pharmaceuticals, Allergan, Bausch Health, Merck, Pfizer, Teva Pharma, Amorphex Therapeutics, Alcon, Astellas Pharma, Bayer, Novartis, AstraZenec here

News-ID: 3084518 • Views:

More Releases from DelveInsight Business Research

Primary Biliary Cholangitis Market Expected to Experience Major Growth by 2034, According to DelveInsight
Primary Biliary Cholangitis Market Expected to Experience Major Growth by 2034, …
DelveInsight's "Primary Biliary Cholangitis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Primary Biliary Cholangitis, historical and forecasted epidemiology as well as the Primary Biliary Cholangitis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Primary Biliary Cholangitis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Primary Biliary Cholangitis
Advanced Renal Cell Carcinoma Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight
Advanced Renal Cell Carcinoma Pipeline 2025: Therapies, MOA Insights, and Key Cl …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Advanced Renal Cell Carcinoma pipeline constitutes 50+ key companies continuously working towards developing 60+ Advanced Renal Cell Carcinoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Advanced Renal Cell Carcinoma Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across
Alport Syndrome Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight
Alport Syndrome Market Forecasted to Surge in Coming Years, 2024-2034 Analysis b …
DelveInsight's "Alport Syndrome Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Alport Syndrome, historical and forecasted epidemiology as well as the Alport Syndrome market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Alport Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Alport Syndrome Market Forecast https://www.delveinsight.com/sample-request/alport-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of the
Angioedema Pipeline 2025: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight
Angioedema Pipeline 2025: FDA Approvals and Clinical Trials Landscape with MOA a …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Angioedema pipeline constitutes 20+ key companies continuously working towards developing 20+ Angioedema treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Angioedema Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed

All 5 Releases


More Releases for Cataract

Transformative Trends Impacting the Cataract Surgery Devices And Equipment Marke …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Cataract Surgery Devices And Equipment Market Size By 2025? The market size for cataract surgery devices and equipment has shown a consistent growth trend in recent years. It is projected to increase from $13.97 billion in 2024 to $14.52 billion in 2025, exhibiting a compound
Cataract Pipeline: Emerging Non-Surgical Solutions and Leading Companies Shaping …
The therapeutic landscape for Cataract, the leading cause of blindness globally, is undergoing a paradigm shift as researchers and biopharmaceutical companies explore non-surgical and disease-modifying alternatives to conventional cataract extraction surgery. Advances in molecular biology, oxidative stress modulation, and crystallin protein stabilization have opened new avenues for pharmacological intervention. Companies like Nacuity Pharmaceuticals, CGeneTech, and Plex Pharmaceuticals are pioneering efforts to develop novel agents aimed at delaying, halting, or reversing
Cataract Surgery Devices Market - Innovation Meets Precision: Elevate Cataract S …
Newark, New Castle, USA: The "Cataract Surgery Devices Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Cataract Surgery Devices Market: https://www.growthplusreports.com/report/cataract-surgery-devices-market/7846 This latest report researches the industry structure,
Intraocular Lens Implants for Cataract Market is Driven by the Increasing Incide …
The proposed Intraocular Lens Implants for Cataract Market report will encompass all the qualitative & quantitative aspects including the market size, market estimates, growth rates & forecasts & hence will give you a holistic view of the market. The study also includes detailed analysis of market drivers, restraints, technological advancements & competitive landscape along with various micro & macro factors influencing the market dynamics. The Intraocular Lens Implants for Cataract Market
Potential Opportunities of Cataract Surgical Devices Market
The global cataract surgical devices market size is projected to reach USD 9.98 billion by the end of 2026. The high prevalence of cataract disorders will open up a huge potential for market growth. According to a report published by Fortune Business Insights, titled "Cataract Surgical Devices Market Size, Share & Industry Analysis, By Product Type (Phacoemulsification Systems, Femtosecond Laser, Intraocular Lenses, Ophthalmic Viscoelastic Devices & Other Consumables), By End-user
Cataract Surgery Devices Market Opportunity Analysis, 2018-2026
Cataract surgery devices are used during the surgical procedures to treat cataract, which is an eye disorder that causes clouding of the lens leading to defects in vision. Cataract is one of the most widespread disease causing blindness and it reduces vision ability. Cataract is often encountered to develop slowly and affect either one or both the eyes. Although cataract does not interfere with the eyesight in the early stages, it